Novartis exits India's mass-market generics, signalling a deeper split between MNC innovation bets and domestic pharma scale
Popular Posts
-
The Allahabad High Court has observed that there can be no room for discrimination or high-handedness when investigating agencies instruct ...
-
Following the Supreme Court's fury over an NCERT textbook on judicial corruption, this op-ed explores the 5.4 crore case backlog, prohi...
